The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $74.32

Today's change0.00 0.00%
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $74.32

Today's change0.00 0.00%
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.

Eli Lilly and Co closed at (U.S.)$74.32.

Over the last five days, shares have lost 6.04% and are down 11.80% for the last year to date. This security has outperformed the S&P 500 by 12.92% during the last year.

Key company metrics

  • Open(U.S.) $74.16
  • Previous close(U.S.) $74.32
  • High(U.S.) $75.82
  • Low(U.S.) $73.55
  • Bid / Ask-- / --
  • YTD % change-11.80%
  • Volume6,312,782
  • Average volume (10-day)5,514,943
  • Average volume (1-month)5,181,495
  • Average volume (3-month)5,334,225
  • 52-week range(U.S.) $68.31 to (U.S.) $92.85
  • Beta0.25
  • Trailing P/E32.88×
  • P/E 1 year forward20.98×
  • Forward PEG1.61×
  • Indicated annual dividend(U.S.) $2.04
  • Dividend yield2.74%
  • Trailing EPS(U.S.) $2.26
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.07%

Based on its net profit margin of 12.07%, Eli Lilly and Co is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue5,3764,9604,9794,645
Total other revenue--------
Total revenue5,3764,9604,9794,645
Gross profit3,9863,7233,7603,452
Total cost of revenue1,3891,2371,2181,193
Total operating expense4,9763,9984,3424,120
Selling / general / administrative1,7981,5761,6351,524
Research & development1,4441,1431,1701,039
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)34442319364
Other operating expenses, total--------
Operating income400961636525
Interest income (expense), net non-operating---55-50-54
Gain (loss) on sale of assets--------
Other--------
Income before tax4451,048680618
Income after tax478800601530
Income tax, total-342487988
Net income478800601530
Total adjustments to net income--------
Net income before extra. items478800601530
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items478800601530
Inc. avail. to common incl. extra. items478800601530
Diluted net income478800601530
Dilution adjustment------0
Diluted weighted average shares1,0651,0651,0661,067
Diluted EPS excluding extraordinary itemsvalue per share0.450.750.560.50
Dividends per sharevalue per share0.500.500.500.50
Diluted normalized EPSvalue per share0.720.780.840.82